Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 30, 2022
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
Mon, August 29, 2022
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
[ Mon, Aug 29th 2022
] - WOPRAI
Andrew Fein Initiated (VIGL) at Strong Buy and Held Target at $24 on, Aug 29th, 2022
Andrew Fein of HC Wainwright & Co., Initiated "Vigil Neuroscience, Inc." (VIGL) at Strong Buy and Held Target at $24 on, Aug 29th, 2022.
Andrew has made no other calls on VIGL in the last 4 months.
There is 1 other peer that has a rating on VIGL. Out of the 1 peers that are also analyzing VIGL, all agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $11 on, Tuesday, May 17th, 2022
